financetom
Business
financetom
/
Business
/
Update: Dun & Bradstreet Shares Drop After Q4 Earnings, Revenue Miss Consensus
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Dun & Bradstreet Shares Drop After Q4 Earnings, Revenue Miss Consensus
Feb 20, 2025 9:30 AM

12:03 PM EST, 02/20/2025 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph.)

Dun & Bradstreet ( DNB ) shares were down nearly 12% in recent trading on Thursday after its Q4 earnings and revenue missed consensus estimates.

The company reported Q4 adjusted earnings of $0.30 per diluted share, down from $0.32 a year earlier.

Analysts polled by FactSet expected $0.32.

Revenue for the quarter ended Dec. 31 was $631.9 million, up from $630.4 million a year earlier.

Analysts surveyed by FactSet expected $658 million.

For 2025, the company said it expects adjusted EPS of $1.01 to $1.07 per share on revenue of $2.44 billion to $2.5 billion. Analysts surveyed by FactSet expect non-GAAP EPS of $1.10 from sales of $2.52 billion.

Price: 9.31, Change: -1.23, Percent Change: -11.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: KKR Exploring Options to Bring in New Investors for Sylvan
Market Chatter: KKR Exploring Options to Bring in New Investors for Sylvan
Aug 29, 2024
06:57 AM EDT, 08/26/2024 (MT Newswires) -- KKR & Co ( KKR ) is reportedly exploring options for mushroom spawn producer Sylvan, including bringing in new investors, Bloomberg reported Monday, citing unnamed people familiar with the matter. Cited sources said KKR has retained an advisor to explore a continuation fund denominated in yuan. This strategy is being considered as market...
DexCom Launches OTC Glucose Biosensor Stelo
DexCom Launches OTC Glucose Biosensor Stelo
Aug 29, 2024
07:01 AM EDT, 08/26/2024 (MT Newswires) -- DexCom ( DXCM ) said Monday it has launched the over-the-counter glucose biosensor Stelo in the United States. Stelo can be purchased without a prescription, DexCom ( DXCM ) said. Price: 74.29, Change: +0.22, Percent Change: +0.30 ...
B. Riley Financial Receives Non-Compliance Notice From Nasdaq
B. Riley Financial Receives Non-Compliance Notice From Nasdaq
Aug 29, 2024
06:59 AM EDT, 08/26/2024 (MT Newswires) -- B. Riley Financial ( RILY ) said Friday that it received notice from Nasdaq that the company is not in compliance with Nasdaq listing rules due to the delayed filing of its quarterly report on Form 10-Q for the period ended June 30 with the Securities and Exchange Commission. The company has to...
Daqo New Energy Swings to Q2 Adjusted Loss, Revenue Falls
Daqo New Energy Swings to Q2 Adjusted Loss, Revenue Falls
Aug 29, 2024
06:54 AM EDT, 08/26/2024 (MT Newswires) -- Daqo New Energy ( DQ ) reported Monday it swung to an adjusted loss of $1.50 per diluted American depositary share in Q2, compared with adjusted earnings of $1.75 a year earlier. Analysts' estimates were not readily available for comparison. Revenue for the quarter ended June 30 was $219.9 million, down from $636.7...
Copyright 2023-2026 - www.financetom.com All Rights Reserved